Evolution of the Average Target: Dolby Laboratories, Inc.

Evolution of the Target Price: Dolby Laboratories, Inc.

Changes in Analyst Recommendations: Dolby Laboratories, Inc.

29b53909eff.yjqPR3aCGv5LEJdS6iVq5s-wf6R9FvzFZaY17nNNyLM.i0PcFTDdVK4sQvwG3RQ_0YnRGu8FeMmwLch8mSIKhfuyCO4kN_FzvCZdwg~5df284eb4dc5c27b3b8b7f9e02c7e4be
11-19 Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating MT
25-09-05 Baird Initiates Dolby Laboratories at Neutral With $74 Price Target MT
25-08-15 Dolby Laboratories' Immersive Media Innovation, Strategic Partnerships to Drive Long-Term Growth, Tigress Financial Partners Says MT
25-08-15 Tigress Adjusts Price Target on Dolby Laboratories to $114 From $112, Maintains Buy Rating MT
24-06-03 Barrington Upgrades Dolby Laboratories to Outperform From Market Perform, Price Target is $100 MT
23-08-04 Rosenblatt Adjusts Price Target on Dolby Laboratories to $98 From $93, Maintains Buy Rating MT
23-02-03 Rosenblatt Adjusts Price Target on Dolby Laboratories to $90 From $85, Maintains Buy Rating MT
22-11-18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform as Economic Challenges Results in Lower Volumes MT
22-11-18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform MT
22-11-07 Rosenblatt Adjusts Price Target on Dolby Laboratories to $85 From $90, Maintains Buy Rating MT
22-10-14 Tigress Financial Cuts Dolby Laboratories' Price Target to $116 From $128 'on Near-Term Valuation Rerating;' Buy Rating Kept MT
22-05-24 Rosenblatt Starts Dolby Laboratories at Buy With $90 Price Target MT
22-05-12 Barrington Research Lowers Price Target for Dolby Laboratories to $90 From $115, Maintains Outperform Rating MT
21-08-02 DOLBY LABORATORIES : Barrington Upgrades Dolby Laboratories to Outperform From Market Perform "as New Initiatives Supplement Progress", Sets $115 Price Target MT
21-01-29 DOLBY LABORATORIES : B. Riley Adjusts Dolby Laboratories' Price Target to $89 From $79, Keeps Neutral Rating MT
21-01-04 DOLBY LABORATORIES : Barrington Research Downgrades Dolby Laboratories to Market Perform From Outperform MT
20-11-13 DOLBY LABORATORIES : JP Morgan Adjusts Price Target for Dolby Laboratories to $90 From $78, Maintains Overweight Rating MT
20-11-13 DOLBY LABORATORIES : B. Riley Adjusts Dolby Laboratories' Price Target to $79 from $73, Keeps Neutral Rating MT
20-11-13 DOLBY LABORATORIES : Barrington Research Adjusts PT on Dolby Laboratories to $95 From $83, Citing 'Meaningful Positive Momentum;' Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+57.11%
+35.3%
+40.55%
+40.18%
+25.59%
- - +72.89%
+53.24%
Average +46.41%
Weighted average by Cap. +39.28%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
49.86USD
Average target price
78.33USD
Spread / Average Target
+57.11%
High Price Target
90.00USD
Spread / Highest target
+80.51%
Low Price Target
60.00USD
Spread / Lowest Target
+20.34%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barrington Research
Baird
Tigress Financial
Rosenblatt Securities
B. Riley
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
49.86USD
Average target price
78.33USD
Spread / Average Target
+57.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DLB Stock
  4. Consensus Dolby Laboratories, Inc.